Drug Profile
Valrubicin - Valderm
Alternative Names: Topical valrubicin; Valrubicin creamLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Valderm
- Class Anthracyclines; Antineoplastics; Cytostatics; Small molecules
- Mechanism of Action DNA intercalators; DNA repair enzyme inhibitors; Type II bacterial DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Plaque psoriasis
Most Recent Events
- 26 Aug 2015 Discontinued - Phase-II for Plaque psoriasis in Germany (Topical)
- 17 Sep 2011 Valderm completes its phase IIa trial for Plaque psoriasis in Germany